Table 2 Clinical characteristics of patients
From: Human neural stem cell transplantation in ALS: initial results from a phase I trial
Patient (Code) | Group | Age | Sex | ALS-FRS-R Score | FVC | Disease duration at entry | Follow up duration |
|---|---|---|---|---|---|---|---|
(%) | (Months from symptoms onset) | (Months from surgery to death (†) or to the last visit) | |||||
740 | A1 | 30 | M | 25 | 74 | 60 | 18 |
746 | A1 | 57 | M | 28 | 64 | 68 | 8† |
753 | A1 | 54 | F | 29 | 83 | 16 | 8† |
766 | A2 | 35 | M | 30 | 82 | 72 | 12 |
767 | A2 | 67 | F | 35 | 88 | 36 | 8† |
779 | A2 | 38 | M | 24 | 82 | 24 | 7 |